Traws Pharma Inc (TRAW) — Cash Flow-to-Debt Ratio
Traws Pharma Inc (TRAW) has a Cash Flow-to-Debt Ratio of -0.19x as of March 2026, meaning its operating cash flow of $-2.58 Million could theoretically repay 0% of its total liabilities ($13.47 Million) in one year. Check cash flow reinvestment rate of Traws Pharma Inc to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Traws Pharma Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Traws Pharma Inc across 15 annual periods. Also explore Traws Pharma Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Traws Pharma Inc (2011–2025)
Year-by-year debt coverage analysis for Traws Pharma Inc. For market capitalisation and broader financial context, see TRAW market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.62x | $-18.18 Million | $11.25 Million | ▼ -207.2% |
| 2024 | -0.53x | $-29.79 Million | $56.59 Million | ▲ +64.7% |
| 2023 | -1.49x | $-17.93 Million | $12.01 Million | ▼ -1.4% |
| 2022 | -1.47x | $-16.29 Million | $11.06 Million | ▲ +29.3% |
| 2021 | -2.08x | $-19.49 Million | $9.36 Million | ▼ -24.6% |
| 2020 | -1.67x | $-23.07 Million | $13.81 Million | ▲ +3.0% |
| 2019 | -1.72x | $-20.83 Million | $12.10 Million | ▲ +4.9% |
| 2018 | -1.81x | $-22.70 Million | $12.54 Million | ▼ -20.4% |
| 2017 | -1.50x | $-23.82 Million | $15.84 Million | ▼ -72.2% |
| 2016 | -0.87x | $-15.81 Million | $18.11 Million | ▲ +64.8% |
| 2015 | -2.48x | $-31.31 Million | $12.61 Million | ▼ -2.2% |
| 2014 | -2.43x | $-57.65 Million | $23.71 Million | ▲ +4.0% |
| 2013 | -2.53x | $-61.38 Million | $24.25 Million | ▼ -37632.1% |
| 2012 | 0.01x | $1.63 Million | $242.16 Million | ▲ +106.8% |
| 2011 | -0.10x | $-14.17 Million | $142.88 Million | — |